Pt-xanthene-iodine complex and Pt-xanthene-bromine complex

Information

  • Patent Grant
  • 11912726
  • Patent Number
    11,912,726
  • Date Filed
    Tuesday, December 13, 2022
    a year ago
  • Date Issued
    Tuesday, February 27, 2024
    3 months ago
  • CPC
  • Field of Search
    • US
    • 549 212000
    • 502 171000
    • 502 185000
    • CPC
    • C07F15/0086
    • C07F9/28
    • B01J31/2457
    • C07C45/505
  • International Classifications
    • C07F15/00
    • C07F9/28
    • Disclaimer
      This patent is subject to a terminal disclaimer.
Abstract
Pt-xanthene-iodine complex and Pt-xanthene-bromine complex, and use thereof for catalysis of a hydroformylation reaction.
Description
PT-XANTHENE-IODINE COMPLEX AND PT-XANTHENE-BROMINE COMPLEX

The present invention relates to a Pt-xanthene-iodine complex and Pt-xanthene-bromine complex, and the use thereof for catalysis of a hydroformylation reaction.


C. Botteghi et al., Journal of Molecular Catalysis A: Chemical 200, (2003), 147-156 describes the use of Pt(Xantphos)Cl2 for hydroformylation of 2-tosyloxystyrene.


The problem addressed by the present invention is that of providing a novel complex. The complex here is to afford an enhanced yield in the catalysis of hydroformylation reactions compared to the complex of Pt with Cl2 described in the prior art.


This object is achieved by a complex according to Claim 1.


Complex comprising:


a) Pt;


b) a ligand conforming to the formula (I):




embedded image


where R1, R2, R3, R4, R5, R6, R7, R8 are selected from: —H, —(C1-C12)-alkyl, —(C6-C20)-aryl, and R9, R10 are selected from: —(C1-C12)-alkyl, —(C6-C20)-aryl, and, if R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 are —(C6-C20)-aryl, the aryl ring may have substituents selected from: —(C1-C12)-alkyl, —O—(C1-C12)-alkyl; c) an iodine ligand or bromine ligand.


The expression (C1-C12)-alkyl encompasses straight-chain and branched alkyl groups having 1 to 12 carbon atoms. These are preferably (C1-C8)-alkyl groups, more preferably (C1-C6)-alkyl, most preferably (C1-C4)-alkyl.


Suitable (C1-C12-alkyl groups are especially methyl, ethyl, propyl, isopropyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 2-pentyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 2-hexyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 2,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl, 1-ethyl-2-methylpropyl, n-heptyl, 2-heptyl, 3-heptyl, 2-ethylpentyl, 1-propylbutyl, n-octyl, 2-ethylhexyl, 2-propylheptyl, nonyl, decyl.


The expression (C6-C20-aryl encompasses mono- or polycyclic aromatic hydrocarbyl radicals having 6 to 20 carbon atoms. These are preferably (C6-C14)-aryl, more preferably (C6-C10)-aryl.


Suitable (C6-C20-aryl groups are especially phenyl, naphthyl, indenyl, fluorenyl, anthracenyl, phenanthrenyl, naphthacenyl, chrysenyl, pyrenyl, coronenyl. Preferred (C6-C20-aryl groups are phenyl, naphthyl and anthracenyl.


In one embodiment, R2, R3, R5, R6, R7, R8 are selected from: —(C1-C12)-alkyl, —(C6-C20)-aryl.


In one embodiment, R5, R6, R7, R8 are —(C6-C20)-aryl.


In one embodiment, R5 and R6 are different radicals and R7 and R8 are different radicals.


In one embodiment, R2 and R3 are —(C1-C12)-alkyl.


In one embodiment, R2 and R3 are —CH3.


In one embodiment, R1 and R4 are —H.


In one embodiment, R9 and R10 are —(C1-C12)-alkyl.


In one embodiment, R9 and R10 are —tBu.


In one embodiment, the ligand conforming to the formula (I) has the structure (1):




embedded image


In one embodiment, the complex has exactly one ligand conforming to the formula (I).


In one embodiment, the complex has at least two iodine ligands.


In one embodiment, the complex has exactly two iodine ligands.


In one embodiment, the complex has at least two bromine ligands.


In one embodiment, the complex has exactly two bromine ligands.


As well as the complex per se, the use thereof for catalysis of a hydroformylation reaction is also claimed.


Use of a complex as described above for catalysis of a hydroformylation reaction.


The invention shall be elucidated in more detail hereinbelow with reference to working examples.







EXPERIMENTAL DESCRIPTION

A vial was charged with PtX2 (X=halogen), ligand, and an oven-dried stirrer bar. The vial is then sealed with a septum (PTFE-coated styrene-butadiene rubber) and phenolic resin cap.


The vial is evacuated and refilled with argon three times. Toluene and 1-octene were added to the vial using a syringe. The vial was placed in an alloy plate, which was transferred to an autoclave of the 4560 series from Parr Instruments under an argon atmosphere. After purging the autoclave three times with CO/H2, the synthesis gas pressure was increased to 40 bar at room temperature. The reaction was conducted at 80° C. for 18 h. On termination of the reaction, the autoclave was cooled to room temperature and cautiously decompressed. Yield and selectivity were determined by GC analysis.


Variation of the Halogen




embedded image


Reaction conditions:


1.0 mmol of 1-octene, 0.5 mol % of PtX2, 2.0 equivalents of ligand (1), solvent: toluene, p(CO/H2): 40 bar, T: 80° C., t: 18 h.


Yields:














Ligand
Halogen
Yield [%]









embedded image


I/Br/Cl
96/24/0









As the experimental results show, the object is achieved by the complex according to the invention.

Claims
  • 1. A complex comprising: a) Pt;b) a ligand conforming to the formula (I):
  • 2. The complex according to claim 1, where R2, R3, R5, R6, R7 and R8 are selected from: —(C1-C12)-alkyl or —(C6-C20)-aryl.
  • 3. The complex according to claim 1where R5, R6, R7 and R8 are —(C6-C20)-aryl.
  • 4. The complex according to claim 1, where R2 and R3 are —(C1-C12)-alkyl.
  • 5. The complex according to claim 1, where R1 and R4 are —H.
  • 6. The complex according to claim 1, where R9 and R10 are —(C1-C12)-alkyl.
  • 7. The complex according to claim 1, wherein the ligand conforming to the formula (I) has the structure (1):
  • 8. The complex according to claim 1, wherein the complex has exactly one ligand conforming to the formula (I).
  • 9. The complex according to claim 1, wherein the complex has at least two iodine ligands.
  • 10. The complex according to claim 9, wherein the complex has exactly two iodine ligands.
  • 11. The complex according to claim 1, wherein the complex has at least two bromine ligands.
  • 12. The complex according to claim 11, wherein the complex has exactly two bromine ligands.
Priority Claims (1)
Number Date Country Kind
21215337 Dec 2021 EP regional
US Referenced Citations (12)
Number Name Date Kind
20100048959 Sigl et al. Feb 2010 A1
20100286440 Kimmich et al. Nov 2010 A1
20190211040 Boerner et al. Jul 2019 A1
20230191384 Schneider et al. Jun 2023 A1
20230191385 Schneider et al. Jun 2023 A1
20230192581 Schneider et al. Jun 2023 A1
20230192582 Schneider et al. Jun 2023 A1
20230192583 Schneider et al. Jun 2023 A1
20230192584 Schneider et al. Jun 2023 A1
20230192740 Schneider et al. Jun 2023 A1
20230192741 Schneider et al. Jun 2023 A1
20230192743 Schneider et al. Jun 2023 A1
Foreign Referenced Citations (4)
Number Date Country
200835678 Sep 2008 TW
201041844 Dec 2010 TW
2010129030 Nov 2010 WO
2017191310 Nov 2017 WO
Non-Patent Literature Citations (19)
Entry
U.S. Appl. No. 18/064,945, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,946, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,947, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,948, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,949, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,950, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,953, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,955, Schneider et al., filed Dec. 13, 2022.
U.S. Appl. No. 18/064,958, Schneider et al., filed Dec. 13, 2022.
Botteghi, C. et al. Synthesis of 2-chromanol by hydroformylation of 2-hydroxystyrene derivatives. Journal of Molecular Catalysis A: Chemical 200. 2003. pp. 147-156.
European Search Report dated May 30, 2022 for European Patent Application No. 21215337.3 (8 pages in German with English Translation).
Petöcz, G., et al. Xantphos as cis- and trans-chelating ligand in square-planar platinum(II) complexes. Hydroformylation of styrene with platinum-xantphos-tin(II)chloride system. Journal of Organometallic Chemistry. 2004. vol. 689, No. 7, pp. 1188-1193.
European Office Action dated Aug. 21, 2023 for European Patent Application No. 21215337.3 (5 pages in German with English translation).
Van der Veen, Lars A., et al. Wide bite angle amine, arsine and phosphine ligands in rhodium- and platinum/tin-catalysed hydroformylation. J Chem. Soc., Dalton Trans. 2000 pp. 2105-2112.
Meessen, Patric, et al. Highly regioselective hydroformylation of internal, functionalized olefins applying PT* Sn complexes with large bite angle diphosphines. Journal of Organometallic Chemistry 551. 1998. vol. 551 pp. 165-170.
Taiwan Ofice Action and Search Report dated Aug. 25, 2023 for Taiwan Patent Application No. 111147943 (4 pages in Chinese; 3 pages English Translation).
Translation of First Examination Report for Saudi Arabia Patent Application No. 122440887, dated Jun. 2023 (3 pages).
Duren, van, R. Platinum catalyzed hydroformylation. [Phd—Thesis 1 (Research TU/e / Graduation TU/e), Chemical Engineering and Chemistry]. Technische Universiteit Eindhoven. Jan. 1, 2004. 119 pages.
Zhang, Yang et al. Binuclear Pd(I)-Pd(I) Catalysis Assisted by Iodide—Ligands for Selective Hydroformylation of Alkenes and Alkynes. American Chemical Society. Oct. 9, 2020. vol. 142, pp. 18251-18265.
Related Publications (1)
Number Date Country
20230192742 A1 Jun 2023 US